Periodic Reporting for period 3 - INFRADYNAMICS (Overcoming the Barriers of Brain Cancer Treatment: Targeted and Fully NIR Absorbing Photodynamic Therapy Agents with Extremely Low Molecular Weights and Controlled Lipophilicity)

Every other day we hear more good news about an advancement towards treating cancer, the truth however is quite a different story when it comes to brain cancers. The state of the art clinically used agent temozolomide increases patient survival only by several months in...